Literature DB >> 6834782

A comfortable, minimum stress method of restraint for Yucatan miniature swine.

L M Panepinto, R W Phillips, S Norden, P C Pryor, R Cox.   

Abstract

For comfortable, minimal-stress restraint of Yucatan miniature swine, a heavy cotton duck sling reinforced with nylon webbing and covered with vinyl was used. The sling was designed with four leg openings and one hole for access to the anterior vena cava. Custom padding was used to line the leg holes and minimize chafing. Five sling sizes were developed for the restraint of any size Yucatan miniature pig (3 to 75 kg) or other pigs up to 150 kg. A steel frame on wheels was designed with or without a boat winch crank mechanism to support the interchangeable slings. The pig restraint was accomplished by lifting or hoisting the animal, depending on animal size.

Entities:  

Mesh:

Year:  1983        PMID: 6834782

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  11 in total

1.  Pharmacokinetic interaction between itraconazole and ceftriaxone in Yucatan miniature pigs.

Authors:  A Cavalier; D Levêque; J D Peter; J Salmon; H Elkhaïli; Y Salmon; P Nobelis; J Geisert; H Monteil; F Jehl
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

2.  Pharmacokinetic interaction between itraconazole and rifampin in Yucatan miniature pigs.

Authors:  G Kaltenbach; D Levêque; J D Peter; J Salmon; H Elkhaili; A Cavalier; Y Salmon; H Monteil; F Jehl
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 3.  Guidelines for animal exercise and training protocols for cardiovascular studies.

Authors:  David C Poole; Steven W Copp; Trenton D Colburn; Jesse C Craig; David L Allen; Michael Sturek; Donal S O'Leary; Irving H Zucker; Timothy I Musch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-20       Impact factor: 4.733

4.  A Method to Administer Agents to the Larynx in an Awake Large Animal.

Authors:  Abigail Durkes; M Preeti Sivasankar
Journal:  J Speech Lang Hear Res       Date:  2017-11-09       Impact factor: 2.297

5.  Ex vivo pharmacodynamics of amoxicillin-clavulanate against beta-lactamase-producing Escherichia coli in a yucatan miniature pig model that mimics human pharmacokinetics.

Authors:  Stéphane Bronner; Valérie Murbach; Jean-Daniel Peter; Dominique Levêque; Hassan Elkhaïli; Yves Salmon; Nathalie Dhoyen; Henri Monteil; Gary Woodnutt; François Jehl
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

6.  Effects of diet-induced obesity on metabolic parameters and reproductive function in female Ossabaw minipigs.

Authors:  Annie E Newell-Fugate; Jessica N Taibl; Sherrie G Clark; Mouhamad Alloosh; Michael Sturek; Rebecca L Krisher
Journal:  Comp Med       Date:  2014-02       Impact factor: 0.982

7.  Effects of Obesity and Metabolic Syndrome on Steroidogenesis and Folliculogenesis in the Female Ossabaw Mini-Pig.

Authors:  Annie E Newell-Fugate; Jessica N Taibl; Mouhamad Alloosh; Michael Sturek; Janice M Bahr; Romana A Nowak; Rebecca L Krisher
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

8.  Effects of coconut oil on glycemia, inflammation, and urogenital microbial parameters in female Ossabaw mini-pigs.

Authors:  Annie E Newell-Fugate; Katherine Lenz; Cassandra Skenandore; Romana A Nowak; Bryan A White; Andrea Braundmeier-Fleming
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

9.  Sling Training with Positive Reinforcement to Facilitate Porcine Wound Studies.

Authors:  Hsin-Ya Yang; Kristopher G Galang; Anthony Gallegos; Betty W Ma; Roslyn Rivkah Isseroff
Journal:  JID Innov       Date:  2021-04-30

10.  The effects of repeated automated plasmapheresis in goats (Capra hircus) in response to vaccination with purified influenza hemagglutinin proteins.

Authors:  Willie D Taylor; Gregory L Langham; James L Weed; Thomas Rowe; Wei Song; Kristin A Isenberg; Xiyan Xu; David E Wentworth; George Lathrop; Nathaniel Powell
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.